Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1964 Jul-Aug:72:222-9.

Control of fertility with oral medication

A W Diddle, G F Watts, W H Gardner, P J Williamson
  • PMID: 12305556

Control of fertility with oral medication

A W Diddle et al. West J Surg Obstet Gynecol. 1964 Jul-Aug.

Abstract

PIP: 447 women were treated with either norethindrone, norethindrone acetate or norethindrone with ethinyl estradiol to prevent conception. The total length of time patients remained under treatment varied from 1 to 60 months for an over-all total experience of 8308 cycles. Only 1 woman conceived, and she had not followed instructions. 4 others were pregnant when treatment was instituted, as learned by hindsight. 58 women conceived within 1 to 12 months after they discontinued medication taken previously for periods of time ranging from 1 to 31 months. Most conceived within 3 months. None of the women suffered thrombophelbitis. Breakthrough uterine bleeding was more common with the administration of norethindrone or norethindrone acetate than with norethindrone acetate combined with ethinyl estradiol. Nausea, retention of fluid, and mastalgia were more common with the progestin-estrogen combination. Ophthalmologic examinations, 17-ketosteroid studies, follicle-stimulating hormone analysis, and blood cholesterol determinations on patients selected at random and after varying periods of treatment were within normal limits.

PubMed Disclaimer

Similar articles

See all similar articles

MeSH terms